These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 8113123)
1. The importance of schedule and drug dose intensity in combinations of modalities. Kallman RF Int J Radiat Oncol Biol Phys; 1994 Feb; 28(3):761-71. PubMed ID: 8113123 [TBL] [Abstract][Full Text] [Related]
2. Schedule-dependent therapeutic gain from the combination of fractionated irradiation plus c-DDP and 5-FU or plus c-DDP and cyclophosphamide in C3H/Km mouse model systems. Kallman RF; Rapacchietta D; Zaghloul MS Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):227-32. PubMed ID: 1991683 [TBL] [Abstract][Full Text] [Related]
3. The effect of treatment in fractionated schedules with the combination of X-irradiation and six cytotoxic drugs on the RIF-1 tumor and normal mouse skin. Lelieveld P; Scoles MA; Brown JM; Kallman RF Int J Radiat Oncol Biol Phys; 1985 Jan; 11(1):111-21. PubMed ID: 4038500 [TBL] [Abstract][Full Text] [Related]
4. Schedule-dependent therapeutic gain from the combination of fractionated irradiation and cis-diamminedichloroplatinum (II) in C3H/Km mouse model systems. Kanazawa H; Rapacchietta D; Kallman RF Cancer Res; 1988 Jun; 48(11):3158-64. PubMed ID: 2966671 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic enhancement in mice by clinically relevant dose and fractionation schedules of cis-diamminedichloroplatinum (II) and irradiation. Bartelink H; Kallman RF; Rapacchietta D; Hart GA Radiother Oncol; 1986 May; 6(1):61-74. PubMed ID: 3715061 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 modulatory effect on the action of chemotherapeutic drugs and localized irradiation of the lip, duodenum, and tumor. Zaghloul MS; Dorie MJ; Kallman RF Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):417-25. PubMed ID: 8514539 [TBL] [Abstract][Full Text] [Related]
7. Effect of docetaxel on the therapeutic ratio of fractionated radiotherapy in vivo. Mason KA; Kishi K; Hunter N; Buchmiller L; Akimoto T; Komaki R; Milas L Clin Cancer Res; 1999 Dec; 5(12):4191-8. PubMed ID: 10632360 [TBL] [Abstract][Full Text] [Related]
8. Effects of fractionated schedules of irradiation combined with cis-diamminedichloroplatinum II on the SCCVII/St tumor and normal tissues of the C3H/KM mouse. Tanabe M; Godat D; Kallman RF Int J Radiat Oncol Biol Phys; 1987 Oct; 13(10):1523-32. PubMed ID: 3624028 [TBL] [Abstract][Full Text] [Related]
9. Multiple drug chemotherapy combined with multiple fractions per day (MFD) radiotherapy in an experimental solid tumor model. Hopkins HA; Looney WB; Carter WH; Reto DC; Campbell ED In Vivo; 1994; 8(1):107-12. PubMed ID: 8054501 [TBL] [Abstract][Full Text] [Related]
10. Effects of matrix-associated chemotherapy in combination with irradiation in vivo. Howes AE; Herman TS; Montoya VP; Luck EE; Brown DM NCI Monogr; 1988; (6):141-3. PubMed ID: 3352756 [TBL] [Abstract][Full Text] [Related]
12. 5-Fluorouracil infusions and fractionated doses of radiation: studies with a murine squamous cell carcinoma. Weinberg MJ; Rauth AM Int J Radiat Oncol Biol Phys; 1987 Nov; 13(11):1691-9. PubMed ID: 3667376 [TBL] [Abstract][Full Text] [Related]
13. Flavopiridol increases therapeutic ratio of radiotherapy by preferentially enhancing tumor radioresponse. Mason KA; Hunter NR; Raju U; Ariga H; Husain A; Valdecanas D; Neal R; Ang KK; Milas L Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1181-9. PubMed ID: 15234054 [TBL] [Abstract][Full Text] [Related]
14. Induction thermochemotherapy increases therapeutic gain factor for the fractionated radiotherapy given to a mouse fibrosarcoma. Kuroda M; Urano M; Nishimura Y; Reynolds R Int J Radiat Oncol Biol Phys; 1997 May; 38(2):411-7. PubMed ID: 9226330 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the enhancement of tumor responses to fractionated irradiation by SR 4233 (tirapazamine) and by nicotinamide with carbogen. Dorie MJ; Menke D; Brown JM Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):145-50. PubMed ID: 8270435 [TBL] [Abstract][Full Text] [Related]
16. Relationship of tumor regrowth to tumor cell survival, tumor cure rates and host survival in a solid tumor model following combined chemotherapy and radiotherapy. Hopkins HA; Looney WB; Carter WH; Reto DC; Campbell ED In Vivo; 1994; 8(1):97-105. PubMed ID: 8054518 [TBL] [Abstract][Full Text] [Related]
17. Solid tumor models for the assessment of different treatment modalities: VIII. The scheduling of treatment for a chemotherapeutically resistant experimental solid tumor. Looney WB; Hopkins HA; MacLeod MS Cancer; 1979 Apr; 43(4):1201-10. PubMed ID: 445323 [TBL] [Abstract][Full Text] [Related]
18. Comparison of in vivo efficacy of hypoxic cytotoxin tirapazamine and hypoxic cell radiosensitizer KU-2285 in combination with single and fractionated irradiation. Shibata T; Shibamoto Y; Sasai K; Oya N; Murata R; Takagi T; Hiraoka M; Abe M Jpn J Cancer Res; 1996 Jan; 87(1):98-104. PubMed ID: 8609056 [TBL] [Abstract][Full Text] [Related]
19. Enhancement of tumor radiation response by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid. Wilson WR; Li AE; Cowan DS; Siim BG Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):905-8. PubMed ID: 9845119 [TBL] [Abstract][Full Text] [Related]
20. Chemopotentiation in vivo: no loss of sensitization with fractionation. Hill SA; Siemann DW Br J Cancer; 1984 Oct; 50(4):509-17. PubMed ID: 6487517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]